|

Targeted therapy Clinical Trials

3 actively recruiting trials

▲ +1 trial since June 2026

Also known as: Anlotinib (CHIATAI TIANQING PHARMACEUTICAL GROUP, China), RTK inhibitor

Pipeline

Phase 2: 3

Top Sponsors

  • Shunda Du1
  • Pengyuan Liu1
  • Fudan University1

Indications

  • Cancer3
  • Liver Disease1
  • Advanced Colorectal Carcinoma1
  • Hepatocellular Carcinoma (HCC)1
  • Immunotherapy1

Other3 trials

Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer
Phase 2
Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC
Phase 2
Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.